Performance characteristics of prostate-specific antigen density and biopsy primary Gleason score to predict biochemical failure in patients with intermediate prostate cancer who underwent radical prostatectomy

References

• SiegelRLMillerKDJemalACancer statistics, 2018CA Cancer J Clin201868173029313949
   PubMed Web of Science ®Google Scholar
• BaadePDYouldenDRKrnjackiLJInternational epidemiology of prostate cancer: geographical distribution and secular trendsMol Nutr Food Res200953217118419101947
   PubMed Web of Science ®Google Scholar
• D’AmicoAVWhittingtonRMalkowiczSBBiochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancerJAMA1998280119699749749478
   PubMed Web of Science ®Google Scholar
• ReeseACPierorazioPMHanMPartinAWContemporary evaluation of the National Comprehensive Cancer Network prostate cancer risk classification systemUrology20128051075107922995570
   PubMed Web of Science ®Google Scholar
• GrossfeldGDLatiniDMLubeckDPPredicting disease recurrence in intermediate and high-risk patients undergoing radical prostatectomy using percent positive biopsies: results from CaPSUREUrology200259456056511927314
   PubMed Web of Science ®Google Scholar
• AbernMRAronsonWJTerrisMKDelayed radical prostatectomy for intermediate-risk prostate cancer is associated with biochemical recurrence: possible implications for active surveillance from the search databaseProstate201373440941722996686
   PubMed Web of Science ®Google Scholar
• LoebSBerglundAStattinPPopulation based study of use and determinants of active surveillance and watchful waiting for low and intermediate risk prostate cancerJ Urol201319051742174923727309
   PubMed Web of Science ®Google Scholar
• CooperbergMRCowanJEHiltonJFOutcomes of active surveillance for men with intermediate-risk prostate cancerJ Clin Oncol201129222823421115873
   PubMed Web of Science ®Google Scholar
• National Comprehensive Cancer NetworkClinical Practice Guidelines in Oncology Prostate CancerNCCN2017 [version 2; February 21, 2017 Available from: https://www.nccn.org/professionals/physician_gls/PDF/prostate.pdfAccessed June 4, 2017
   Google Scholar
• ZumstegZSSprattDEPeiIA new risk classification system for therapeutic decision making with intermediate-risk prostate cancer patients undergoing dose-escalated external-beam radiation therapyEur Urol201364689590223541457
   PubMed Web of Science ®Google Scholar
• JungJWLeeJKHongSKByunSSLeeSEStratification of patients with intermediate-risk prostate cancerBJU Int2015115690791224612460
   PubMed Web of Science ®Google Scholar
• EpsteinJIAminMBReuterVEHumphreyPAContemporary Gleason grading of prostatic carcinoma: an update with discussion on practical issues to implement the 2014 International Society of Urological Pathology (ISUP) Consensus conference on Gleason grading of prostatic carcinomaAm J Surg Pathol2017414e1e728177964
   PubMed Web of Science ®Google Scholar
• AlendaOPloussardGMouracadePImpact of the primary Gleason pattern on biochemical recurrence-free survival after radical prostatectomy: a single-center cohort of 1,248 patients with Gleason 7 tumorsWorld J Urol201129567167621107843
   PubMed Web of Science ®Google Scholar
• HermanCMKattanMWOhoriMScardinoPTWheelerTMPrimary Gleason pattern as a predictor of disease progression in Gleason score 7 prostate cancer: a multivariate analysis of 823 men treated with radical prostatectomyAm J Surg Pathol200125565766011342779
   PubMed Web of Science ®Google Scholar
• AminAPartinAEpsteinJIGleason score 7 prostate cancer on needle biopsy: relation of primary pattern 3 or 4 to pathological stage and progression after radical prostatectomyJ Urol201118641286129021862072
   PubMed Web of Science ®Google Scholar
• BurdickMJReddyCAUlchakerJComparison of biochemical relapse-free survival between primary Gleason score 3 and primary Gleason score 4 for biopsy Gleason score 7 prostate cancerInt J Radiat Oncol Biol Phys20097351439144518963536
   PubMed Web of Science ®Google Scholar
• BensonMCWhangISPantuckAProstate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancerJ Urol19921473 Pt 28158161371554
   PubMed Web of Science ®Google Scholar
• BuschJHamborgKMeyerHAValue of prostate specific antigen density and percent free prostate specific antigen for prostate cancer prognosisJ Urol201218862165217023083861
   PubMed Web of Science ®Google Scholar
• KunduSDRoehlKAYuXAntenorJASuarezBKCatalonaWJProstate specific antigen density correlates with features of prostate cancer aggressivenessJ Urol2007177250550917222621
   PubMed Web of Science ®Google Scholar
• MagheliAHinzSHegeCProstate specific antigen density to predict prostate cancer upgrading in a contemporary radical prostatec-tomy series: a single center experienceJ Urol2010183112613219913257
   PubMed Web of Science ®Google Scholar
• RadwanMHYanYLulyJRProstate-specific antigen density predicts adverse pathology and increased risk of biochemical failureUrology20076961121112717572199
   PubMed Web of Science ®Google Scholar
• BrassellSAKaoTCSunLMoulJWProstate-specific antigen versus prostate-specific antigen density as predictor of tumor volume, margin status, pathologic stage, and biochemical recurrence of prostate cancerUrology20056661229123316360448
   PubMed Web of Science ®Google Scholar
• FreedlandSJWiederJAJackGSDoreyFDekernionJBAronsonWJImproved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason scoreJ Urol2002168111011512050502
   PubMed Web of Science ®Google Scholar
• FreedlandSJKaneCJPrestiJCComparison of preoperative prostate specific antigen density and prostate specific antigen for predicting recurrence after radical prostatectomy: results from the search data baseJ Urol2003169396997312576824
   PubMed Web of Science ®Google Scholar
• HorningerWRogatschHReissiglACorrelation between preoperative predictors and pathologic features in radical prostatectomy specimens in PSA-based screeningProstate1999401566110344724
   PubMed Web of Science ®Google Scholar
• NaritaSMitsuzukaKTsuchiyaNReassessment of the risk factors for biochemical recurrence in D’Amico intermediate-risk prostate cancer treated using radical prostatectomyInt J Urol201522111029103526290306
   PubMed Web of Science ®Google Scholar
• LauWKBluteMLBostwickDGWeaverALSeboTJZinckeHPrognostic factors for survival of patients with pathological Gleason score 7 prostate cancer: differences in outcome between primary Glea-son grades 3 and 4J Urol200116651692169711586204
   PubMed Web of Science ®Google Scholar
• ChanTYPartinAWWalshPCEpsteinJIPrognostic significance of Gleason score 3+4 versus Gleason score 4+3 tumor at radical prosta-tectomyUrology200056582382711068310
   PubMed Web of Science ®Google Scholar
• KangHWJungHDLeeJYProstate-specific antigen density predicts favorable pathology and biochemical recurrence in patients with intermediate-risk prostate cancerAsian J Androl201618348048426178393
   PubMed Web of Science ®Google Scholar